Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

50
How To Benefit From The Autonomous Vehicle Trend Starting As Soon As 2019

11h seekingalpha
Autonomous vehicles timeline - GM to launch fully autonomous EV robo-taxis in the US in 2019.
LMT FB SSNLF NFLX NVDA NOC GM.WS.A GM.WS.B AAPL GM.WS.C GM INTC BIDU VLKAY STM SFBTF BC94 MA SMSN BSWQY DDAIF COL SNEJF V GOOGL MU SNE QCOM GM.WSB APTV SMSD

21
What Should Investors Do With Tesla (TSLA) Stock?

2018-07-16 zacks
Shares of Tesla (TSLA - Free Report) plummeted Monday after chief executive Elon Musk once again found himself in hot water after he posted a rude comment about a British cave explorer regarding the Thailand cave rescue mission. Although the CEO’s statements were crass, they don’t really impact Tesla’s core business. So let’s assess TSLA stock at what could be a buying point.
GM.WS.A TWTR GM.WS.B GM.WS.C GM GM.WSB VLKAY

18
Auto Stock Roundup: TSLA Hikes Prices in China, F to Absorb Tariffs, GM in Focus

2018-07-12 zacks
In the past week, electric vehicle (EV) manufacturer Tesla, Inc. (TSLA - Free Report) raised prices of Model X and Model S vehicles by 20% in China. In fact, Tesla is the first automaker to increase prices in the world’s largest automotive market. Moreover, the company inked a deal to build its first factory outside the United States. With this factory in Shanghai, Tesla will be the first wholly-owned foreign automaker in China.
VLKAF GM.WS.A GM.WS.B ADI GM.WS.C PCAR GM HOG GM.WSB AAP VLKAY

32
An Investor's Test Drive Of The Autonomous BEV Pitch

2018-07-12 seekingalpha
The pitch for self-driving cars is almost too good to be true promising zero crashes, zero emissions, and zero congestion.
DLR.PRH DLR.PRG DLR.PRJ DLR.PRI NVDA DDAIF HMC VLKAF GOOGL GM.WS.A GM.WS.B AAPL GM.WS.C DLR GM QCOM INTC GM.WSB DLR.PRC VLKAY DLR.PRF

54
Mercedes' Go-To-Market Plan For The EQC, Its First Proper All-Electric Car

2018-07-10 seekingalpha
Mercedes to unveil the final production of its first proper volume electric car (EQC) this fall, with mass production to be underway in 2019.
VLKAF TSLA DDAIF DMLRY VLKPY VLKAY TTM

14
What Is Tesla's China Strategy?

2018-07-10 seekingalpha
On July 8, Tesla announced that it would be raising its prices in China in response to rising tariffs.
PCRFY GM.WS.A GM.WS.B GM.WS.C GM GM.WSB VLKAY

13
Liberty Media Formula One Group, Volkswagen, Twitter and Facebook highlighted as Zacks Bull and Bear of the Day

2018-07-10 zacks
Chicago, IL – July 10, 2018 – Zacks Equity Research highlights Liberty Media Formula One Group (FWONA - Free Report) as the Bull of the Day, Volkswagen (VLKAY - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onTwitter (TWTR - Free Report) and Facebook (FB - Free Report) .
FB TWTR LXFR HEAR DLB LYV VLKAY NCS SXC

235
Stocks To Watch: A New Beverage Giant Steps Out

2018-07-07 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
GNK GIS JWN CIT EDR DUKH AMC ENTG PDYPF INFY KORS MSFT OXY HELE LMT KKR TM KLIC WFC.PRL WFC.PRJ LB MPC BAC WFC.PRT ZION WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN CCL KO WFC.PRY INTC WDFC WFC.PRX WFC.PRW WFC.PRV LUV NCLH DUK VRCA HMC OTC JPM ZUMZ TSLA ESPR TTM TOL HA RCL UAL KEY CATO CHRA ALGT VLKAY OSTK RNLSY BAC NJR OTEX FAST BKE CCL MDLZ HOG CMI PNC INFY AHBIF FOXA WFCNP RNSDF JBLU USX NEW WIMHY ALK GS MYL JEF GRKGF DAL DIS ABEV WFC WIMHF WFC.WS BUD C CMCSA COST BCNQY WMH SNY AVLR PEP SNE

3
Albemarle: Long-Term Lithium And Electric Vehicle Play

2018-07-05 seekingalpha
Albemarle (ALB) is a specialty chemicals company with significant lithium operations. The company derives 36% of revenue from the lithium business and is considered the industry leader for lithium and lithium derivatives. The stock has been lagging this year as the market has been hung up on supply fears. However, I think the supply fears are overblown. Albemarle is not likely to be affected due to its long-term contracts with customers.
ALB VLKAY

3
Volkswagen to Start Car Sharing Service With EVs in Germany

2018-07-05 zacks
Per Reuters, Volkswagen AG (VLKAY - Free Report) has planned to introduce car-sharing services with all-electric cars in 2019. The company will initially launch the service in Germany, later expanding to other major cities of Europe, Asia and North America by early 2020.
VLKAF VC MGA AXL MG VLKAY

19
Auto Stock Roundup: June Sales Rise, Tariff Woes Loom, TSLA Achieves Model 3 Target

2018-07-05 zacks
The week saw the release of the auto sales report for the month of June. U.S. auto sales jumped in the month, defying the odds of rising interest rates, higher gas prices and large supply of used vehicles. While the first half of the year saw auto sales rise 1.8%, sales in June increased 5% compared with a year ago. Strong consumer confidence and low level of unemployment boosted auto sales. There is however the lurking fear of this joyride being derailed due to President Trump’s proposed tariffs.
DTK HOG JMPLF CMI VLKAF GM.WS.A GM.WS.B ALV GM.WS.C JMPLY GM GM.WSB AAP VLKAY

0
Trade Tariffs Will Adversely Impact The Automotive Sector

2018-07-04 seekingalpha
There will be significant winners and losers to the current U.S.-E.U. trade war, but none more so than in the automotive sector.
TM DMLRY VLKAY

3
Volkswagen's Skoda Invests EUR 1B in INDIA 2.0 Campaign

2018-07-04 zacks
Volkswagen AG (VLKAY - Free Report) has announced an investment of €1 billion between 2019 and 2021 for the implementation of its planned model campaign, INDIA 2.0, for the Indian market. The campaign will be led by Volkswagen’s Skoda Auto brand. Further, a project center for vehicle development will also be set up in the country to maintain proximity to the market and understand the requirement of targeted customers.
VLKAF VC BLT MGA BHP AXL BHPBF MG BBL BHP BHPLF VLKAY

33
Should You Buy Tesla (TSLA) Stock On Model 3 Production Progress?

2018-07-02 zacks
Shares of Tesla (TSLA - Free Report) opened higher on Monday morning, only to sink later on, after the company announced that it produced more than 5,000 Model 3 vehicles during the last seven days of the second quarter. Now, the question is should investors buy Tesla stock since the electric vehicle firm finally reached its production goal for its mass-market Model 3 sedan.
WFC WFCNP WFC.WS WFC.PRL WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO GM.WS.A WFC.PRN GM.WS.B GM.WS.C GM WFC.PRY WFC.PRX GM.WSB WFC.PRW VLKAY WFC.PRV

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 928662303